~~<i id='A17B9A3330'><strike id='A17B9A3330'><tt id='A17B9A3330'><pre id='A17B9A3330'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

focus

author：Wikipedia 2025-10-01 02:12:59 - browse：27776

Pharmacy shelves — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Change Healthcare outage fallout shows need for new oversight

focus

hotspot

leisure time

explore

focus

knowledge

PabloMartinezMonsivais/APIn2023,enrollmentinMedicareAdvantage,theversionofMedicarerunbyprivateinsure

WSS

Why scientists need input from humanists on sensitive research

Boston's new lab space is opening empty

Medicare Advantage isn’t working — for anyone

First U.S. drug developed to treat liver disease MASH is approved

5 ways to address the shortage of health care workers

Why depression after traumatic brain injury is distinct

entertainment

focus

focus

New air purifier tech could be key to improving indoor air quality

Male and female sex labels in research insufficient, scientists say

At least 13 dead in Texas as scorching temps continue

WuXi out of biotech trade group, U.S. and China relations to blame

Supreme Court strikes down use of affirmative action

5 ways to address the shortage of health care workers

Duchenne breakthrough therapy leaves behind pioneering families

Change Healthcare outage fallout shows need for new oversight

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

NEJM study measures Covid brain fog, impact on IQ

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Amid AI frenzy, a top HHS official's quest to create safeguards

leisure time

explore

focus

knowledge